Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eastman Chemical (EMN) EBT (2016 - 2026)

Eastman Chemical (EMN) has disclosed EBT for 18 consecutive years, with $136.0 million as the latest value for Q1 2026.

  • For Q1 2026, EBT fell 46.25% year-over-year to $136.0 million; the TTM value through Mar 2026 reached $451.0 million, down 59.62%, while the annual FY2025 figure was $568.0 million, 47.31% down from the prior year.
  • EBT hit $136.0 million in Q1 2026 for Eastman Chemical, up from $12.0 million in the prior quarter.
  • Across five years, EBT topped out at $425.0 million in Q4 2023 and bottomed at $12.0 million in Q4 2025.
  • Average EBT over 5 years is $226.2 million, with a median of $253.0 million recorded in 2025.
  • Year-over-year, EBT surged 1417.86% in 2023 and then crashed 95.96% in 2025.
  • Eastman Chemical's EBT stood at $28.0 million in 2022, then soared by 1417.86% to $425.0 million in 2023, then plummeted by 30.12% to $297.0 million in 2024, then plummeted by 95.96% to $12.0 million in 2025, then skyrocketed by 1033.33% to $136.0 million in 2026.
  • According to Business Quant data, EBT over the past three periods came in at $136.0 million, $12.0 million, and $134.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.